@CovidComunidad @_diatoma @foreign_laura @LauraMiers @D_Bone @inducekarmaaa @ahandvanish @calirunnerdoc @carlos_arnaud Este solo es un artículo de revisión. Hubiese sido interesante para decidir darlo, un estudio en pacientes y analizar sus desenlaces, com
RT @Nitroba30704324: @LobservateurLi2 Prend-t-elle vit D (monter à 8ug/ml) zinc et ivermectine ou fluvoxamine https://t.co/Jm9QcXbA9x
@LobservateurLi2 Prend-t-elle vit D (monter à 8ug/ml) zinc et ivermectine ou fluvoxamine https://t.co/Jm9QcXbA9x
RT @emma_sar: Según evidencia, la fluvoxamina podría reducir ligeramente la mortalidad, así como el riesgo de ingreso hospitalario en pacie…
RT @emma_sar: Según evidencia, la fluvoxamina podría reducir ligeramente la mortalidad, así como el riesgo de ingreso hospitalario en pacie…
RT @emma_sar: Según evidencia, la fluvoxamina podría reducir ligeramente la mortalidad, así como el riesgo de ingreso hospitalario en pacie…
RT @emma_sar: Según evidencia, la fluvoxamina podría reducir ligeramente la mortalidad, así como el riesgo de ingreso hospitalario en pacie…
Según evidencia, la fluvoxamina podría reducir ligeramente la mortalidad, así como el riesgo de ingreso hospitalario en pacientes ambulatorios con covid-19. Fluvoxamine for the treatment of COVID‐19 - Nyirenda, JLZ - 2022 | Cochrane Library https://t.co/D
Le but étant de sauver des vies humaines, son usage à l'hôpital aussi serait à envisager: overall mortality was lower in the fluvoxamine group Safety & efficacy of fluvoxamine in C19 ICU patients: An open label prospective cohort trial w/ matched contr
@MikiLaMalice @gayets Cochrane est pas si convaincu mais peut être que ça fonctionne. Et si on a des preuves solides ne t'inquiètes pas que fe sera prescrit. Comme la dexamethasone. https://t.co/S7YmYHyNum
RT @CochraneNursing: 🦠💊氟伏沙明是治療COVID‐19的有效方法嗎? 📍 The abstract and plain language summary in Chinese can be found here 🔗 https://t.co/YOsQ8SN…
@CurfewX @quarkytea @JJWUrology @gorskon There was some studies that show it may have an impact by reducing inflamnation but limited in numbers and quality. https://t.co/4aypOuJbo2. It's a more research needed kinda thing and since vaccines reduce the seve
RT @CochraneNursing: 🦠💊氟伏沙明是治療COVID‐19的有效方法嗎? 📍 The abstract and plain language summary in Chinese can be found here 🔗 https://t.co/YOsQ8SN…
RT @CochraneNursing: 🦠💊氟伏沙明是治療COVID‐19的有效方法嗎? 📍 The abstract and plain language summary in Chinese can be found here 🔗 https://t.co/YOsQ8SN…
RT @CochraneNursing: 🦠💊氟伏沙明是治療COVID‐19的有效方法嗎? 📍 The abstract and plain language summary in Chinese can be found here 🔗 https://t.co/YOsQ8SN…
🦠💊氟伏沙明是治療COVID‐19的有效方法嗎? 📍 The abstract and plain language summary in Chinese can be found here 🔗 https://t.co/YOsQ8SNgNV @CochraneLibrary #CochraneReview #Chinesetranslation @CochraneNursing #CochraneHongKong #CochraneChinaNetwork #cuhknursing https://t.c
@seb_a_volonte @Clara_Locher @MaxDelvallee @SebastienRubin @MathieuMolimard @SFPT_fr L'étude vient juste se rajouter au faisceau de preuves qui montre que la fluvoxamine a à un effet à de doses qui elles ne provoquent pas d'effets secondaires, selon la rev
COVID‐19の治療におけるフルボキサミンの効果 https://t.co/sFgYuaVCHk
RT @AntxonApinaniz: #Fluvoxamine COVID-19 tratamendurako. #cochrane 2022ko irailaren 14a #zientzia #koronabirusa #COVID19 https://t.co/1Pb…
#Fluvoxamine COVID-19 tratamendurako. #cochrane 2022ko irailaren 14a #zientzia #koronabirusa #COVID19 https://t.co/1Pbz85eVQ0
RT @CochraneUK: What are the benefits and harms of #fluvoxamine for adults with mild #COVID19? ➡️ Read the new @CochraneLibrary Clinical An…
RT @CochraneLibrary: What are the benefits and harms of #fluvoxamine for adults with mild #COVID19? ➡️ Read the new @CochraneLibrary Clinic…
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUeyQN
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUeyQN
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUeyQN
RT @CochraneUK: What are the benefits and harms of #fluvoxamine for adults with mild #COVID19? Read the new @CochraneLibrary Clinical Answe…
What are the benefits and harms of #fluvoxamine for adults with mild #COVID19? ➡️ Read the new @CochraneLibrary Clinical Answer: https://t.co/ndeFTqY5h5 📃 Read the plain language summary and full review: https://t.co/yUhBsedCZh #CochraneClinicalAnswers h
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUeyQN
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUf6Gl
RT @CochraneLibrary: 💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Syste…
@AngelaReiersen @boulware_dr
RT @CochraneLibrary: 💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Syste…
RT @CochraneLibrary: 💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Syste…
RT @CochraneLibrary: 💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Syste…
💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Systematic Review found 2 completed studies, 5 ongoing studies, & 2 for which we need more info. Current evidence = unclear. https://t.co/
¿Fluvoxamina para tratar la covid‐19? Una nueva revisión de @CochraneHaem concluye que podría reducir ligeramente la mortalidad por todas las causas a los 28 días y el riesgo de ingreso hospitalario o muerte en pacientes ambulatorios con covid‐19 leve: h
La fluvoxamine dans le traitement de la COVID-19 https://t.co/m37fmUeyQN
@DivagoTM @RelativeBrain @adbacchi Fluvoxamina (um antidepressivo!!!) no tratamento de Covid. Interessante, deixei impresso aqui para eu ler amanhã. O que vocês acham? https://t.co/OvK0sfHKAb
Fluvoxamina para el tratamiento d la covid‐19: Con certeza baja, la fluvoxamina puede reducir ligeramente la mortalidad por todas las causas a los 28 días, así como el riesgo d ingreso hospitalario o la muerte en pacientes ambulatorios con covid‐19 leve...
RT @COVID_Evidence: PubMed: Fluvoxamine for the treatment of COVID-19: BACKGROUND: Fluvoxamine is a selective serotonin reuptake inhibitor…
RT @CochraneLibrary: 💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Syste…
💊 Is fluvoxamine an effective treatment for people with #COVID19 ? Does it cause any unwanted effects? 📚 Living Systematic Review found 2 completed studies, 5 ongoing studies, & 2 for which we need more information. Current evidence = unclear. https:
Fluvoxamine for treating COVID-19 | Cochrane https://t.co/Vf71CJcaNi
PubMed: Fluvoxamine for the treatment of COVID-19: BACKGROUND: Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that has been approved for the treatment of depression, obsessive-compulsive disorder, and a… https://t.co/c4lW49QQaD #covid19 #S